![]() |
![]() |
Robert de Vries, Ph.D. The Scripps Research Institute 10550 North Torrey Pines Road, CB-216 La Jolla, CA 92037 858-784-7537 (phone) 858-784-7542 (fax) rvries@scripps.edu |
|
|
EDUCATION 2012: Ph.D., Virology, Utrecht University 2007: MSc., Biology, University of Amsterdam 2005: B.Sc., Biomedical Science, University of Amsterdam PROFESSIONAL EXPERIENCES: March 2012 to Present - Postdoctoral Fellow, The Scripps Research Institute, La Jolla, CA, USA (Advisor: Prof. James C. Paulson) August 2011: Lecturer at Infection & Immunity International Summer school, Utrecht University, the Netherlands November 1, 2007 to January 1, 2012 - Doctoral Candidate, Virology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, the Netherlands (Advisors: Prof. Peter J.M. Rottier & Dr. Xander (C) A.M. de Haan) November 1, 2007 to January 1, 2012 - Supervising practical lessons during the yearly Virology course, Utrecht University, the Netherlands September 1, 2007 to January 11, 2007 - Teaching Assistant, Department of Cell Biology, Universtiy of Amsterdam, the Netherlands (Supervisor: Dr. Tannke den Blaauwen) February 1, 2007 to June 1, 2007: Research Internship, Torrey Pines Institute for Molecular Studies, San Diego, USA (Supervisor: Dr. James Binley) March 1, 2006 to December 1, 2006: Research Internship, Experimental Virology, Amsterdam Medical Centre, the Netherlands (Supervisor: Dr. Rogier Sanders) ACADEMIC AND PROFESSIONAL HONORS: 2012-2014: NWO Rubicon Fellowship 2009-present: Member of the Dutch Society for Glycobiology 2011: Young investigator award Dutch Society for Microbiology 2007: Organon Pharmaceuticals/Dr. Saal van Zwanenberg Fellowship 2007: Bekker La Bastide Fellowship PUBLICATIONS: de Vries RP, Smit CH, de Bruin E, Rigter A, de Vries E, Cornelissen LA, Eggink D, Chung NP, Moore JP, Sanders RW, Hokke CH, Koopmans M, Rottier PJ, de Haan CA (2012) Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin. J Virol. Aug 22. [Epub ahead of print] de Vries E, de Vries RP, Wienholts MJ, Floris CE, Jacobs MS, van den Heuvel A, Rottier PJ, de Haan CA (2012) Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci U S A. 109(19):7457-62. Wickramasinghe IN, de Vries RP, Grone A, de Haan CA, Verheije MH (2011) Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity. J Virol 85: 8903-8912. Melchers M, Matthews K, de Vries RP, Eggink D, van Montfort T, et al. (2011) A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells. Retrovirology 8: 48. Loeffen WL, de Vries RP, Stockhofe N, van Zoelen-Bos D, Maas R, et al. (2011) Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus. Vaccine 29: 1545-1550. de Vries RP, de Vries E, Moore KS, Rigter A, Rottier PJ, et al. (2011) Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin. J Biol Chem 286: 5868-5875. de Vries RP, de Vries E, Bosch BJ, de Groot RJ, Rottier PJ, et al. (2010) The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity. Virology 403: 17-25. Cornelissen LA, de Vries RP, de Boer-Luijtze EA, Rigter A, Rottier PJ, et al. (2010) A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 5: e10645. Bosch BJ, Bodewes R, de Vries RP, Kreijtz JH, Bartelink W, et al. (2010) Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol 84: 10366-10374. Crooks ET, Moore PL, Franti M, Cayanan CS, Zhu P, et al. (2007) A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 366: 245-262. |
| HOME | RESEARCH | PUBLICATIONS | GROUP MEMBERS | OTHER RESOURCES |